ACTRN12617000840381已完成未知
Phase II randomised controlled trial evaluation of treatment decision-aid for patients with bipolar II disorder and their family considering treatment options for relapse prevention.
A/Prof Ilona Juraskova0 个研究点目标入组 196 人开始时间: 2017年6月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 196
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Educational / counselling / training
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •i) Confirmed clinical diagnosis of bipolar II disorder;
- •ii) Out of acute episode of depression and/or hypomania (i.e., subsyndromal or euthymic);
- •iii) Actively considering treatment options for relapse prevention in bipolar II disorder with a clinician (e.g., GP, psychiatrist or clinical psychologist).
排除标准
- •i) Lacks English proficiency to read the decision-aid and/or complete questionnaires;
- •ii) Lacks capacity to provide informed consent to research;
- •iii) Comorbid substance abuse disorder;
- •iv) Comorbid neurological or major psychiatric condition.
研究者
相似试验
进行中（未招募）
1 期
eoadjuvant Nivolumab and chemotherapy in stage I-II triple negative breast cancer.Early stage triple negative breast cancerEUCTR2019-003465-18-ITBreast Cancer Trials108
进行中（未招募）
1 期
eoadjuvant Nivolumab and chemotherapy in stage I-II triple negative breast cancer.CTIS2024-512625-86-00ANZ Breast Cancer Trials Group Limited110
已完成
不适用
An exploratory study of dignity therapy for older people in care homesISRCTN37589515King's College London (UK)64
已完成
2 期
An exploratory study of Dignity Therapy for people with advanced cancerAdvanced cancerMalignant neoplasm of other and ill-defined sitesCancerISRCTN29868352King's College London (UK)40
已完成
2 期
Randomized phase II trial to evaluate the effectiveness of azacitidine for low risk MDS.lower risk myelodysplastic syndromeJPRN-UMIN000010855ational Research Group on Idiopathic Bone Marrow Failure Syndromes100